Chong Kun Dang Pharmaceutical (185750.KS)
Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair color medication, as well as insecticides. The company also exports its products. Chong Kun Dang Pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.
Company Info
Highlights
₩1.13T
₩1.63T
₩523.49B
₩70,900.00 - ₩122,474.77
₩124,571.43
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Chong Kun Dang Pharmaceutical (185750.KS) returned -2.70% year-to-date (YTD) and -11.90% over the past 12 months. Over the past 10 years, 185750.KS returned 4.83% annually, underperforming the S&P 500 benchmark at 10.85%.
185750.KS
-2.70%
6.39%
-2.79%
-11.90%
3.73%
4.16%
4.83%
^GSPC (Benchmark)
0.51%
3.96%
-2.00%
12.02%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of 185750.KS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -2.70% | -6.70% | -3.71% | 4.88% | 6.13% | -2.70% | |||||||
| 2024 | -15.97% | -1.64% | 1.85% | -5.35% | 0.19% | -6.32% | 13.89% | 11.57% | -9.65% | -8.54% | -7.88% | -0.09% | -27.72% |
| 2023 | -0.61% | -3.06% | -1.90% | 9.15% | 4.01% | -6.81% | -5.97% | 12.69% | 7.82% | 1.17% | 30.45% | 11.99% | 68.87% |
| 2022 | -16.85% | 4.12% | 2.39% | 0.61% | -6.26% | -5.71% | 2.97% | -4.66% | -8.50% | 6.87% | -0.36% | 4.20% | -21.43% |
| 2021 | -18.98% | -6.81% | -19.30% | 0.72% | -6.12% | 4.98% | -5.11% | -0.77% | -6.59% | -2.49% | -9.36% | 10.39% | -48.09% |
| 2020 | -4.23% | -7.00% | -1.62% | 13.53% | -2.18% | 14.94% | 24.42% | 43.70% | -14.43% | -8.13% | 14.10% | 37.31% | 146.32% |
| 2019 | 3.92% | -0.94% | -2.86% | -0.00% | -9.71% | 0.11% | -5.21% | -5.15% | 0.60% | 14.75% | -4.18% | 12.10% | 0.78% |
| 2018 | 5.78% | -7.18% | -1.54% | -8.24% | -10.26% | -4.29% | 3.98% | 3.83% | 8.76% | -26.53% | 18.22% | 5.41% | -18.08% |
| 2017 | -6.22% | 11.73% | 0.91% | 5.43% | 6.01% | -1.21% | -7.79% | -7.56% | 4.33% | 3.69% | 19.56% | 3.65% | 33.41% |
| 2016 | 49.32% | -10.80% | 8.20% | -19.13% | 2.23% | -3.49% | 0.90% | -10.49% | 1.20% | -8.22% | 7.12% | 6.13% | 9.66% |
| 2015 | -14.24% | 4.29% | 16.95% | 4.98% | 19.39% | 5.72% | -9.39% | -12.07% | 6.80% | -17.14% | 31.35% | 15.50% | 48.22% |
| 2014 | 1.76% | 7.35% | 5.77% | -6.85% | -4.63% | -3.29% | -5.02% | 9.18% | 8.97% | -7.06% | -2.81% | -4.33% | -3.07% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 185750.KS is 35, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Chong Kun Dang Pharmaceutical (185750.KS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Chong Kun Dang Pharmaceutical provided a 1.27% dividend yield over the last twelve months, with an annual payout of ₩1,100.00 per share. The company has been increasing its dividends for 9 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₩1,100.00 | ₩1,100.00 | ₩1,047.62 | ₩907.03 | ₩863.84 | ₩783.53 | ₩671.59 | ₩671.59 | ₩609.16 | ₩609.16 | ₩406.10 | ₩541.47 |
Dividend yield | 1.27% | 1.24% | 0.84% | 1.22% | 0.90% | 0.42% | 0.88% | 0.88% | 0.65% | 0.86% | 0.62% | 1.23% |
Monthly Dividends
The table displays the monthly dividend distributions for Chong Kun Dang Pharmaceutical. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | |||||||
| 2024 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩1,100.00 | ₩1,100.00 |
| 2023 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩1,047.62 | ₩1,047.62 |
| 2022 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩907.03 | ₩907.03 |
| 2021 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩863.84 | ₩863.84 |
| 2020 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩783.53 | ₩783.53 |
| 2019 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩671.59 | ₩671.59 |
| 2018 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩671.59 | ₩671.59 |
| 2017 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩609.16 | ₩609.16 |
| 2016 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩609.16 | ₩609.16 |
| 2015 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩406.10 | ₩406.10 |
| 2014 | ₩541.47 | ₩541.47 |
Dividend Yield & Payout
Dividend Yield
Chong Kun Dang Pharmaceutical has a dividend yield of 1.27%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Chong Kun Dang Pharmaceutical has a payout ratio of 16.11%, which is below the market average. This means Chong Kun Dang Pharmaceutical returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Chong Kun Dang Pharmaceutical. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Chong Kun Dang Pharmaceutical was 68.75%, occurring on Oct 13, 2022. The portfolio has not yet recovered.
The current Chong Kun Dang Pharmaceutical drawdown is 55.66%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -68.75% | Dec 22, 2020 | 445 | Oct 13, 2022 | — | — | — |
| -56.47% | Jan 25, 2016 | 1020 | Mar 23, 2020 | 92 | Aug 4, 2020 | 1112 |
| -40.49% | Jul 7, 2015 | 74 | Oct 22, 2015 | 50 | Jan 5, 2016 | 124 |
| -30.87% | Oct 24, 2014 | 71 | Feb 4, 2015 | 70 | May 20, 2015 | 141 |
| -28.98% | Aug 21, 2020 | 48 | Nov 2, 2020 | 34 | Dec 18, 2020 | 82 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Chong Kun Dang Pharmaceutical over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Chong Kun Dang Pharmaceutical, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -47.9%.
Valuation
The Valuation section provides an overview of how Chong Kun Dang Pharmaceutical is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 185750.KS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 185750.KS has a P/S ratio of 0.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 185750.KS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 185750.KS has a P/B value of 1.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |